Below are current clinical trials.
Filter this list of studies by location, status and more.
Rochester, Minn.
The purposes of this study are to determine whether maternal T cells are activated and expand after in utero intervention, and to determine whether placental macrophages and histology in the maternal-fetal interface exhibit increased activation and inflammation in surgical cases born preterm (<37 weeks) compared to term.
Rochester, Minn., Minneapolis, Minn.
The purpose of this study is to evaluate the continued safety and probable benefit of the MID-C system for 5 years post-implantation in Adolescent Idiopathic Scoliosis (AIS).
The purpose of this study is to evaluate the long-term safety and tolerability of NBI-921352 when administered for up to 106 weeks. Also, to investigate the effect of NBI-921352 on long-term seizure control.
The purpose of this study is to understand the role of systemic inflammation in the genesis of seizures in susceptible children by gaining a clearer understanding of the spectrum of inflammatory responses that occur in healthy children post-vaccinations.
The purpose of this study is to evaluate patterns of and changes in secretion levels of the stress hormone, cortisol and other steroid hormones (i.e. DHEA, testosterone, progesterone) from hair samples of 150 pediatric patients with chronic pain and a parent or caregiver upon admission and at 3 and 6 months after participation in Mayo Clinic’s intensive, interdisciplinary pediatric pain treatment program.
The purpose of the study is to learn more about adolescent and young adults' experience with chronic pain. In particular, we are studying factors which lead to pain-associated disability and factors which predict decreased disability during and after participation in a three-week intensive treatment program. In addition to gathering information from the young people with chronic pain, parents are also asked to give their perspective.
The purpose of this study is to systematically and prospectively record accurate and complete data regarding the clinical presentation, treatment, and outcomes of patients diagnosed with RB; collect, bank, preserve, and analyze biomaterials from patients with RB, and to correlate phenotypic data with findings from human biomaterials.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.